基本信息
views: 43
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
Michel Kranendonk received his PhD in Chemistry (Molecular Toxicology) from the Vrije Universiteit Amsterdam (Netherlands), for research performed at the UT Southwestern Medical Center at Dallas (US), Universidade NOVA de Lisboa (Portugal) and the Vrije Universiteit Amsterdam and conducted postdoctoral research at the Universidade NOVA de Lisboa. In 2010, he was appointed Principal Investigator at the NOVA Medical School (Universidade NOVA de Lisboa). In addition to his research career, currently heading the Xenobiotic Metabolism research group of the Research Center for Toxicogenomics & Human Health (ToxOmics), Michel Kranendonk is lecturer of multiple PhD and MSc programmes in genetics, toxicology, and drug metabolism. He has supervised national and international students and postdoctoral scientists, and secured training and research funding from national and international sources. He is a past Special Co-editor of Frontiers in Pharmacology, and currently Associated Editor of Frontiers in Pharmacogenetics and Pharmacogenomics and Review Editor of Frontiers in Genetics. Additionally, he was member of the Management Committee of the EU Cost Action Pro EURO DILI Network (2018-2023) and is current member of the EASL DHILI consortium and of the International Advisory Committee of the Cytochrome P450 Conferences.
Research Interests
Papers共 60 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Journal of xenobioticsno. 2 (2024): 575-603
Nádia Vital,Ana Catarina Gramacho, Mafalda Silva, Maria Cardoso,Paula Alvito,Michel Kranendonk,Maria João Silva,Henriqueta Louro
Foods (Basel, Switzerland)no. 11 (2024): 1690
MEDICINEno. 13 (2023)
Cited0Views0Bibtex
0
0
Chemical Research in Toxicologyno. 7 (2022): 1184-1201
Load More
Author Statistics
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn